The global MRI contrast agent market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period (2022-2028). The rising frequency of chronic diseases affecting the brain, spine, and liver, as well as the occurrence of joint injuries in developing nations, however, the cost of MRI diagnostic is prohibitive, limiting the use […]
